T14 key data
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX: T14) has a market capitalization of $3.68B. Last close $2.66; 52-week range $2.45 to $3.75.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX: T14) has a market capitalization of $3.68B. Last close $2.66; 52-week range $2.45 to $3.75.